Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Intellia Therapeutics, Inc. (NTLA) Insider Trading

3 open-market trades reported since Aug 24, 2026: 0 purchases worth $0 and 3 sales worth $310K.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Michael P. DubeCAO0$01$23KOct 6, 2026
John M. LeonardCEO0$02$287KAug 24, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

NTLA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 6Oct 2Michael P. DubeCAOCAO▼ SELL1,86412.43$23K−2.8%Form 4 ↗
Aug 24Aug 20John M. LeonardCEOCEO▼ SELL10b5-119,89012.60$251K−1.7%Form 4 ↗
Aug 24Aug 21John M. LeonardCEOCEO▼ SELL10b5-12,78513.00$36K−0.2%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings